You have requested access to member-only content.

2019 OPPS final rule: CMS focuses on site-neutral payment policies and reducing outpatient volume

Despite facing potential lawsuits and political opposition, CMS finalized some of its most controversial proposals in the 2019 OPPS final rule by implementing several site-neutral payment policies and 340B drug payment reductions.

This is an excerpt from member-only content. Please log in or become a member.

Not a member? Join now!

Revenue Cycle Advisor is the key to your organization's Medicare regulatory news and education. It combines all of HCPro's Medicare regulatory and reimbursement resources into one handy and easy-to-access portal. News is not just repeated from other sources. It is analyzed by our Medicare experts so professionals can comprehend any new rule updates thoroughly.

For questions and support, please call customer service: 800-650-6787.